All mice with increased cTnI levels exhibited clinical deterioration (HUS score = 3, Supplementary Figure 1); however, other mice with comparable disease severity regarding clinical presentation and laboratory values did not present with increased cTnI levels. The gene discussed is TNNI3; the disease is hemolytic-uremic syndrome.